LONDON, May 21 (Reuters) - Switzerland-based Novartis's (NOVN.VX: Quote, Profile, Research pension fund plans to invest four percent of its 14 billion Swiss francs ($11.37 billion) in precious metals, the manager of the pension fund told Reuters on Monday.
"What we want to do is to invest one percent, that is 140 million Swiss francs ($114.1 million), in gold, one percent in platinum, one percent in palladium and one percent in silver, that's more or less half a billion Swiss francs," Andre Ludin, head of portfolio management at drugmaker Novartis AG, told Reuters in a telephone interview.
((Reporting by Atul Prakash, editing by Michael Roddy; Reuters Messaging: atul.prakash.reuters.com@reuters.net; +44 (0) 20 7542 7744))